Literature DB >> 27150970

TgERK7 is involved in the intracellular proliferation of Toxoplasma gondii.

Zhong-Yuan Li1,2,3, Ze-Dong Wang2, Si-Yang Huang1, Xing-Quan Zhu4,5, Quan Liu6.   

Abstract

Toxoplasma gondii uses a unique mechanism to fulfill its asexual life cycles by which the parasite can infect all the warm-blooded animals including humans. Mitogen-activated protein kinase (MAPK) or extracellular signal-regulated kinase (ERK) pathway widely existed in eukaryotic cells mediates the conversion of environmental stimuli to intracellular events such as proliferation and differentiation. Their counterparts have been identified in Apicomplexan parasites such as ERK7 in T. gondii. To confirm whether the unique mechanism of T. gondii is relevant to MAPK/ERK member, we created a mutant (ΔTgERK7) in GT1 tachyzoites using double homologous recombination method. Our results of virulence evaluation showed 100 % survival of all the ΔTgERK7-infected mice until 35 days post-challenge compared to no survival in wild-type GT1-infected group (10.6 ± 0.34 days). Furthermore, lower parasite loads were detected in the peritoneal fluid of ΔTgERK7-infected mice (P < 0.05). To ensure whether or not ERK7 gene knockout leads to the growth deficiency of T. gondii, the intracellular proliferation of ΔTgERK7 was also examined in vitro. Our data indicated that the proliferation of ΔTgERK7 parasites was significantly prolonged in comparison with wild-type GT1 tachyzoites (P < 0.05). Therefore, we concluded that TgERK7 is important for the intracellular proliferation of T. gondii, which further emphasized that MAPK/ERK derived from T. gondii participates in the regulation of the asexual life cycles to ensure the survival and reinfections of this parasite.

Entities:  

Keywords:  Intracellular proliferation; TgERK7; Toxoplasma gondii; Toxoplasmosis

Mesh:

Substances:

Year:  2016        PMID: 27150970     DOI: 10.1007/s00436-016-5103-5

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Activation of the cellular mitogen-activated protein kinase pathways ERK, P38 and JNK during Toxoplasma gondii invasion.

Authors:  A Valère; R Garnotel; I Villena; M Guenounou; J M Pinon; D Aubert
Journal:  Parasite       Date:  2003-03       Impact factor: 3.000

3.  Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers.

Authors:  J P Dubey; D E Hill; J L Jones; A W Hightower; E Kirkland; J M Roberts; P L Marcet; T Lehmann; M C B Vianna; K Miska; C Sreekumar; O C H Kwok; S K Shen; H R Gamble
Journal:  J Parasitol       Date:  2005-10       Impact factor: 1.276

4.  Disruption of lactate dehydrogenase through homologous recombination to improve bioethanol production in Thermoanaerobacterium aotearoense.

Authors:  Youhua Cai; Chaofeng Lai; Shuang Li; Zexin Liang; Mingjun Zhu; Shizhong Liang; Jufang Wang
Journal:  Enzyme Microb Technol       Date:  2010-10-30       Impact factor: 3.493

Review 5.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

Review 6.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

Review 7.  Mitogen-activated protein kinase signaling.

Authors:  Svetlana V Kyosseva
Journal:  Int Rev Neurobiol       Date:  2004       Impact factor: 3.230

8.  Stable DNA transformation of Toxoplasma gondii using phleomycin selection.

Authors:  M Messina; I Niesman; C Mercier; L D Sibley
Journal:  Gene       Date:  1995-11-20       Impact factor: 3.688

9.  The toxoplasma apicoplast phosphate translocator links cytosolic and apicoplast metabolism and is essential for parasite survival.

Authors:  Carrie F Brooks; Hanne Johnsen; Giel G van Dooren; Mani Muthalagi; San San Lin; Wolfgang Bohne; Karsten Fischer; Boris Striepen
Journal:  Cell Host Microbe       Date:  2009-12-31       Impact factor: 21.023

10.  A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation.

Authors:  Laurence Braun; Marie-Pierre Brenier-Pinchart; Manickam Yogavel; Aurélie Curt-Varesano; Rose-Laurence Curt-Bertini; Tahir Hussain; Sylvie Kieffer-Jaquinod; Yohann Coute; Hervé Pelloux; Isabelle Tardieux; Amit Sharma; Hassan Belrhali; Alexandre Bougdour; Mohamed-Ali Hakimi
Journal:  J Exp Med       Date:  2013-09-16       Impact factor: 14.307

View more
  5 in total

1.  Toxoplasma invasion delayed by TgERK7 eradication.

Authors:  Zhong-Yuan Li; Xue Liang; Hai-Ting Guo; Jie Tan; Xing-Quan Zhu; Quan Liu
Journal:  Parasitol Res       Date:  2020-09-11       Impact factor: 2.289

Review 2.  Potential Sabotage of Host Cell Physiology by Apicomplexan Parasites for Their Survival Benefits.

Authors:  Shalini Chakraborty; Sonti Roy; Hiral Uday Mistry; Shweta Murthy; Neena George; Vasundhra Bhandari; Paresh Sharma
Journal:  Front Immunol       Date:  2017-10-13       Impact factor: 7.561

3.  Genome-Wide Identification and Evolutionary Analysis of Sarcocystis neurona Protein Kinases.

Authors:  Edwin K Murungi; Henry M Kariithi
Journal:  Pathogens       Date:  2017-03-21

4.  Loss of a conserved MAPK causes catastrophic failure in assembly of a specialized cilium-like structure in Toxoplasma gondii.

Authors:  William J O'Shaughnessy; Xiaoyu Hu; Tsebaot Beraki; Matthew McDougal; Michael L Reese
Journal:  Mol Biol Cell       Date:  2020-02-19       Impact factor: 4.138

5.  Immune Responses Induced by pVAX/TgERK7 against Toxoplasma gondii Infection in BALB/c Mice.

Authors:  Hai-Ting Guo; Zhong-Yuan Li; Jin-Lei Wang; Zhao-Yu Geng; Xing-Quan Zhu
Journal:  Iran J Parasitol       Date:  2019 Oct-Dec       Impact factor: 1.012

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.